Uncommon phenotypes of BCR::ABL1-positive chronic myelogenous leukemia.
Therapeutic options against BCR-ABL1 T315I-positive chronic myelogenous leukemia.
"Preleukemic or smoldering" chronic myelogenous leukemia (CML):BCR-ABL1 positive: A brief case report.
Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring.
Jabbour E, Kantarjian H.
Am J Hematol. 2024 Nov;99(11):2191-2212. doi: 10.1002/ajh.27443. Epub 2024 Aug 2.
Chronic Myeloid Leukemia: A Review.
Jabbour E, Kantarjian H.
JAMA. 2025 May 13;333(18):1618-1629. doi: 10.1001/jama.2025.0220.
Uncommon phenotypes of BCR::ABL1-positive chronic myelogenous leukemia.
Jajosky AN, Lichtman MA.
Haematologica. 2025 Sep 1;110(9):1912-1920. doi: 10.3324/haematol.2025.287792. Epub 2025 May 15.
Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions.
Osman AEG, Deininger MW.
Blood Rev. 2021 Sep;49:100825. doi: 10.1016/j.blre.2021.100825. Epub 2021 Mar 16.
Response and Resistance to BCR-ABL1-Targeted Therapies.
Braun TP, Eide CA, Druker BJ.
Cancer Cell. 2020 Apr 13;37(4):530-542. doi: 10.1016/j.ccell.2020.03.006.
The specificity of asciminib, a potential treatment for chronic myeloid leukemia, as a myristate-pocket binding ABL inhibitor and analysis of its interactions with mutant forms of BCR-ABL1 kinase.
Manley PW, Barys L, Cowan-Jacob SW.
Leuk Res. 2020 Nov;98:106458. doi: 10.1016/j.leukres.2020.106458. Epub 2020 Sep 29.
Chronic myelogenous leukemia, BCR-ABL1+.
Vardiman JW.
Am J Clin Pathol. 2009 Aug;132(2):250-60. doi: 10.1309/AJCPUN89CXERVOVH.
Suspected chronic myeloid leukemia-like BCR-ABL1-positive acute lymphoblastic leukemia.
Keino D, Kinoshita A, Sudo A, Ohyama R, Mori T.
Pediatr Int. 2021 Jun;63(6):728-729. doi: 10.1111/ped.14474. Epub 2021 May 26.
Chronic Myeloid Leukemia: Beyond BCR-ABL1.
Zhou T, Medeiros LJ, Hu S.
Curr Hematol Malig Rep. 2018 Dec;13(6):435-445. doi: 10.1007/s11899-018-0474-6.
The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1.
Wylie AA, Schoepfer J, Jahnke W, Cowan-Jacob SW, Loo A, Furet P, Marzinzik AL, Pelle X, Donovan J, Zhu W, Buonamici S, Hassan AQ, Lombardo F, Iyer V, Palmer M, Berellini G, Dodd S, Thohan S, Bitter H, Branford S, Ross DM, Hughes TP, Petruzzelli L, Vanasse KG, Warmuth M, Hofmann F, Keen NJ, Sellers WR.
Nature. 2017 Mar 30;543(7647):733-737. doi: 10.1038/nature21702. Epub 2017 Mar 22.
